Astellas Pharma Market Cap

Astellas Pharma has a market cap or net worth of 4.13 trillion as of April 28, 2026. Its market cap has increased by 67.78% in one year.

Market Cap

4.13T

Enterprise Value

4.42T

Revenue

2.14T

Ranking

n/a

PE Ratio

14.22

Stock Price

2,306.00

Market Cap Chart

Since January 14, 1992, Astellas Pharma's market cap has increased from 882.84B to 4.13T, an increase of 367.94%. That is a compound annual growth rate of 4.60%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	4,131.18B	10.19%
Dec 30, 2025	3,749.02B	36.48%
Dec 30, 2024	2,746.92B	-9.13%
Dec 29, 2023	3,022.77B	-17.34%
Dec 30, 2022	3,657.07B	5.52%
Dec 30, 2021	3,465.82B	17.06%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Daiichi Sankyo Company	4,582.67B
Otsuka Holdings	5,700.31B
Chugai Pharmaceutical	14.56T
Kyowa Kirin	1,230.98B
Ono Pharmaceutical	1,104.28B
Santen Pharmaceutical	538.49B
JCR Pharmaceuticals	69.90B
Perseus Proteomics	3.27B

Market Cap Rankings